Plunkett Research Online: SteadyMed

STEADYMED (STDY:NAS) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

SteadyMed Ltd is a specialty pharmaceutical company. It primarily focuses on the development and commercialization of drug product candidates for the treatment of orphan and other diseases with unmet parenteral delivery needs. The company develops two products for the treatment of post-surgical and .....



SteadyMed
Ticker: STDY
Exchange: NAS
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 972 36449556
Fax: 972 36449558
Address: 5 Oppenheimer Street
Rehovot, 7670105 Israel

Types Of Business
Industry Ranks

Industry NAICS code:


Ranks not available
ContactsDescription
Jonathan RigbyCEO/Director/President
David NassifCFO/Chief Accounting Officer/Executive VP
See More
SteadyMed Ltd is a specialty pharmaceutical company. It primarily focuses on the development and commercialization of drug product candidates for the treatment of orphan and other diseases with unmet parenteral delivery needs. The company develops two products for the treatment of post-surgical and .....See More See More

Auditor: KOST FORER GABBAY & KASIERER
Legal Advisor:
$USD, In whole numbers,
except marked * or %
2016201520142013
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and AffiliatesTop Salaries
NameTitleSalary (US$)Bonus (US$)
Other ThoughtsCorporate Culture

Apparent Female Officers or Directors: